235 related articles for article (PubMed ID: 24345442)
1. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
[TBL] [Abstract][Full Text] [Related]
2. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
Womble PR; Linsell SM; Gao Y; Ye Z; Montie JE; Gandhi TN; Lane BR; Burks FN; Miller DC;
J Urol; 2015 Aug; 194(2):403-9. PubMed ID: 25896556
[TBL] [Abstract][Full Text] [Related]
3. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.
Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y
J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
Adibi M; Pearle MS; Lotan Y
BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
[TBL] [Abstract][Full Text] [Related]
6. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK
Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154
[TBL] [Abstract][Full Text] [Related]
7. Infection-related hospital admissions after transrectal biopsy of the prostate.
Sanders A; Buchan N
ANZ J Surg; 2013 Apr; 83(4):246-8. PubMed ID: 23346881
[TBL] [Abstract][Full Text] [Related]
8. Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy.
Recabal P; Lee T; Vertosick E; Manasia M; Eastham J; Touijer K; Seo SK; Spaliviero M; Ehdaie B
World J Urol; 2020 Apr; 38(4):965-970. PubMed ID: 31190154
[TBL] [Abstract][Full Text] [Related]
9. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
10. Variation in prostate cancer detection rates in a statewide quality improvement collaborative.
Riedinger CB; Womble PR; Linsell SM; Ye Z; Montie JE; Miller DC; Lane BR;
J Urol; 2014 Aug; 192(2):373-8. PubMed ID: 24582538
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy.
Antsupova V; Nørgaard N; Bisbjerg R; Nygaard Jensen J; Boel J; Jarløv JO; Arpi M
J Antimicrob Chemother; 2014 Dec; 69(12):3372-8. PubMed ID: 25114164
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
Liss MA; Kim W; Moskowitz D; Szabo RJ
J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
Lee JK; Lee S; Hong SK; Byun SS; Lee SE
BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
[TBL] [Abstract][Full Text] [Related]
14. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
15. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
Jiang P; Liss MA; Szabo RJ
J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
[TBL] [Abstract][Full Text] [Related]
16. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
Nam RK; Saskin R; Lee Y; Liu Y; Law C; Klotz LH; Loblaw DA; Trachtenberg J; Stanimirovic A; Simor AE; Seth A; Urbach DR; Narod SA
J Urol; 2010 Mar; 183(3):963-8. PubMed ID: 20089283
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
[TBL] [Abstract][Full Text] [Related]
19. Prevention of infectious complications after prostate biopsy procedure.
Togo Y; Yamamoto S
Int J Urol; 2017 Jul; 24(7):486-492. PubMed ID: 28556409
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
